Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)
Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021
increase of 463.3 MB and 700.2 MB or increase of 36.6% and 68.0%, respectively. This is because the Company had delivered many large-scale projects which had just been auctioned in early 2019. Those large
745.8 MB or increase of 4.0% and 70.8%, respectively. This is because the Company had delivered many large-scale projects which had been ongoing from Q1–2019 and Q2–2019, such as the High-Speed Internet
157.0 MB and 221.6 MB, respectively. This is because the Company had delivered many large-scale projects which had just been auctioned in Q1–2019. In fact, those large-scale projects had delayed their
establishment of the Company. In fact, the majority of the company’s revenue was revenue from sale and service. In 2019, the Company had received many large-scale projects from government agencies and state
businesses and FinTech startups to make the most of financial innovations, but also promote a full-scale digital economy.?The FinTech Draft Act contains four core matters: (1) strengthening the confidence in
reporting period in case of changes to the securities or derivatives holding by extending reporting periods for small-scale transactions with permission to incorporate small-scale transactions into one report
larger scale,” said SEC Secretary-General Pornanong Budsaratragoon. The knowledge-building activities conducted by participating businesses for the Public Empowerment through Capital Market Knowledge